SCHEMBL4018340

SCHEMBL4018340

O=C(O)Nc1ccccc1-c1ccc(O)c(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACMSD Q8TDX5 1/20 0.50
HCAR2 Q8TDS4 1/20 0.48
LMNA P02545 2/20 0.47
KDM4E B2RXH2 2/20 0.47
HSD17B10 Q99714 1/20 0.47
MCL1 Q07820 2/20 0.46
RAB9A P51151 1/20 0.46
SELL P14151 2/20 0.44
SELP P16109 2/20 0.44
SELE P16581 2/20 0.44
NTRK1 P04629 1/20 0.42
HTT P42858 1/20 0.42
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
APOBEC3A P31941 1/20 0.41
GFER P55789 1/20 0.41
HDAC1 Q13547 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4681312 0.88 CHRM3 (0.50) ACMSDLMNARAB9ANTRK1HTT
SCHEMBL17797038 0.85 CHRM3 (0.53) LMNAKDM4ERAB9ANTRK1HTT
SCHEMBL17797001 0.83 CHRM3 (0.52) LMNAKDM4EHSD17B10RAB9ANTRK1
SCHEMBL4009983 0.82 ESR2 (0.53) HCAR2LMNAKDM4EMCL1SELL
SCHEMBL3906948 0.82 LMNA (0.46) LMNAKDM4EHSD17B10RAB9ANTRK1
SCHEMBL16438538 0.81 LMNA (0.43) LMNAKDM4ERAB9ANTRK1HTT
SCHEMBL3904133 0.81 CHRM3 (0.53) LMNAKDM4ERAB9AMEN1ALDH1A1
SCHEMBL3910619 0.79 ALDH1A1 (0.57) LMNAKDM4ERAB9ANTRK1HTT
SCHEMBL3904710 0.79 RAB9A (0.52) ACMSDLMNAKDM4ERAB9AHTT
SCHEMBL17796942 0.78 CHRM3 (0.53) LMNARAB9ANTRK1HDAC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074094-A1 SULFONAMIDE DERIVATIVES AS ADRENERGIC AGONISTS AND MUSCARINIC ANTAGONISTS Pfizer Limited (GB) 2009-07-01 EP claimed
WO-2008041095-A1 SULFONAMIDE DERIVATIVES AS ADRENERGIC AGONISTS AND MUSCARINIC ANTAGONISTS PFIZER LIMITED (GB) 2008-04-10 WO claimed
EP-2074094-A1 SULFONAMIDE DERIVATIVES AS ADRENERGIC AGONISTS AND MUSCARINIC ANTAGONISTS Pfizer Limited (GB) 2009-07-01 EP disclosed
WO-2008041095-A1 SULFONAMIDE DERIVATIVES AS ADRENERGIC AGONISTS AND MUSCARINIC ANTAGONISTS PFIZER LIMITED (GB) 2008-04-10 WO disclosed